BRST5:Volunteer Assignments and Opportunities: Difference between revisions

[checked revision][checked revision]
No edit summary
No edit summary
Line 306: Line 306:
|
|
|-
|-
|Adenoid Cystic Carcinoma||Disease||Katherine Geiersbach / Jun Liao
|[[Adenoid Cystic Carcinoma]]||Disease||Katherine Geiersbach / Jun Liao
|10/12/02022
|10/12/02022
|11/11/2023
|11/11/2023
Line 315: Line 315:
|2021 template added
|2021 template added
|-
|-
|Secretory Carcinoma||Disease||Hui Chen / Morteza Seifi
|[[Secretory Carcinoma]]||Disease||Hui Chen / Morteza Seifi
|10/12/2022
|10/12/2022
|11/11/2023
|11/11/2023
Line 342: Line 342:
|
|
|-
|-
|Tall Cell Carcinoma with Reversed Polarity||Disease||H. Evin Gulbahce
|[[Tall Cell Carcinoma with Reversed Polarity]]||Disease||H. Evin Gulbahce
|8/11/2023
|8/11/2023
|10/11/2023
|10/11/2023
Line 378: Line 378:
|
|
|-
|-
|Fibroadenoma||Disease||H. Evin Gulbahce / Patricija Zot
|[[Fibroadenoma]]||Disease||H. Evin Gulbahce / Patricija Zot
|8/11/2023
|8/11/2023
|11/11/2023
|11/11/2023
Line 387: Line 387:
|2021 template added
|2021 template added
|-
|-
|Phyllodes Tumour||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
|[[Phyllodes Tumour]]||Disease||H. Evin Gulbahce / Patricija Zot / Emilie Lalonde / Katherine Geiersbach
|8/11/2023
|8/11/2023
|11/11/2023
|11/11/2023
Line 495: Line 495:
|
|
|-
|-
|Inflammatory Myofibroblastic Tumour||Disease||Yajuan Liu
|[[Inflammatory Myofibroblastic Tumour]]||Disease||Yajuan Liu
|8/11/2023
|8/11/2023
|11/11/2023
|11/11/2023
Line 747: Line 747:
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|NOT YET CREATED - See page "Neurofibromatosis Type 1 (NF1)" in GTS5 book to finish first. Then will make this page for this other book to refer to GTS5 page and include this body site's specific content.
|-
|-
|Polygenic Component of Breast Cancer Susceptibility
|[[Polygenic Component of Breast Cancer Susceptibility]]
|Disease
|Disease
|
|
Line 756: Line 756:
|
|
|
|
|
|Template added (12/30/23)
|-
|-
|}<br />
|}<br />